1
The following substances and products, namely:— (a) Acetorphine. Alfentanil. Allylprodine. Alphacetylmethadol. Alphameprodine. Alphamethadol. Alphaprodine. Anileridine. AP-237 (1-[4-([2E]-3-phenyl-2-propen-1-yl)-1-piperazinyl]-1-butanone) (bucinnazine). AP-238 (1-[2,6-dimethyl-4-[2E]-3-phenyl-2-propen-1-yl]-1-piperazinyl-1-propanone). Azaprocin (1-[3-[(E)-3-phenyl-2-propen-1-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]propan-1-one). Benzethidine. Benzylmorphine (3-benzylmorphine). Betacetylmethadol. Betameprodine. Betamethadol. Betaprodine. Bezitramide. Brorphine. Bufotenine. Butonitazene. ... ... Carfentanil. Clonitazene. Coca leaf. Cocaine. Desomorphine. Dextromoramide. Diamorphine. Diampromide. Diethylthiambutene. Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid). Dihydrocodeinone O -carboxymethyloxime. Dihydroetorphine Dimenoxadole. Dimepheptanol. Dimethylthiambutene. Dioxaphetyl butyrate. Diphenoxylate. Dipipanone. Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol). Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine. Ethyleneoxynitazene. Ethylmethylthiambutene. Eticyclidine. Etodesnitazene (etazene). Etonitazene. Etorphine. Etoxeridine. Etryptamine Fentanyl. Flunitazene. Fungus (of any kind) which contains psilocin or an ester of psilocin. Furethidine. Hydrocodone. Hydromorphinol. Hydromorphone. Hydroxypethidine. Isomethadone. Isotonitazene. Ketobemidone. Levomethorphan. Levomoramide. Levophenacylmorphan. Levorphanol. Lofentanil Lysergamide. Lysergide and other N -alkyl derivatives of lysergamide. Mescaline. Metazocine. Methadone. Methadyl acetate. Methylamphetamine Methyldesorphine. Methyldihydromorphine (6-methyldihydromorphine). Metodesnitazene (metazene). Metonitazene. Metopon. Morpheridine. Morphine. Morphine methobromide, morphine N -oxide and other pentavalent nitrogen morphine derivatives. Myrophine. ... Nicomorphine (3,6-dinicotinoylmorphine). Noracymethadol. Norlevorphanol. Normethadone. Normorphine. Norpipanone. Opium, whether raw, prepared or medicinal. Oxycodone. Oxymorphone. para-methyl-AP-237 (1-[4-[2E]-3-(4-methylphenyl)-2-propen-1-yl]-1-piperazinyl-1-butanone). para-nitroazaprocin (1-[3-[(E)-3-(4-nitrophenyl)-2-propen-1-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl)propan-1-one). Pethidine. Phenadoxone. Phenampromide. Phenazocine. Phencyclidine. Phenomorphan. Phenoperidine. Piminodine. Piritramide. Poppy-straw and concentrate of poppy-straw. Proheptazine. Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester). Protonitazene. Psilocin. Racemethorphan. Racemoramide. Racemorphan. Remifentanil Rolicyclidine. Sufentanil. Tapentadol. Tenocylidine. Thebacon. Thebaine. Tilidate. Trimeperidine. (6a R, 9 R )-4-acetyl -N,N -diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide (ALD-52). 4-Bromo-2,5-dimethoxy-a-methylphenethylamine . 4-Cyano-2-dimethylamino-4,4-diphenylbutane. 4-Cyano-1-methyl-4-phenyl-piperidine. 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45). N -Desethyl etonitazene. N -Desethylisotonitazene. N- Desethyl protonitazene. 3,4-dichloro- N -[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921); 3,4-dichloro- N -[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47,700). (6aR,9R) R, 9 R )- N,N- diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide (AL-LAD); (6aR,9R) R, 9 R ) -N,N- diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3 -fg ]quinoline-9-carboxamide (ETH-LAD); (6aR,9R) R, 9 R )- N,N- diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide (PRO-LAD). N,N -Diethyltryptamine. 2,4-dimethylazetidinyl{(6a R, 9 R )-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinolin-9-yl}methanone (LSZ). N,N -Dimethyltryptamine. 2,5-Dimethoxy-a,4-dimethylphenethylamine. N-Hydroxy-tenamphetamine. 1-Methyl-4-phenylpiperidine-4-carboxylic acid. 2-Methyl-AP-237 (1-[2-methyl-4-[2E]-3-phenyl-2-propen-1-yl]-1-piperazinyl-1-butanone). 2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid. 4-Methyl-aminorex 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR). 4-Phenylpiperidine-4-carboxylic acid ethyl ester. N -Piperidinyl-etonitazene (etonitazepipne). N -Pyrrolidino-etonitazene (etonitazepyne). N- Pyrrolidino protonitazene. (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say— (i) by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure; (ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; (iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents; (iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent; (ba) the following phenethylamine derivatives, namely:— Allyl( a -methyl-3,4-methylenedioxyphenethyl)amine 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol 2-Amino-1-(3,4-dimethoxyphenyl)ethanol Benzyl( a -methyl-3,4-methylenedioxyphenethyl)amine 4-Bromo- b ,2,5-trimethoxyphenethylamine N -(4- sec -Butylthio-2,5-dimethoxyphenethyl)hydroxylamine Cyclopropylmethyl( a -methyl-3,4-methylenedioxyphenethyl)amine 2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)ethylamine 2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)-1-methylethylamine 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine 2-(1,4-Dimethoxy-2-naphthyl)ethylamine 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine N -(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine a , a -Dimethyl-3,4-methylenedioxyphenethylamine a , a -Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine Dimethyl( a -methyl-3,4-methylenedioxyphenethyl)amine N -(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine 4-Iodo-2,5-dimethoxy- a -methylphenethyl(dimethyl)amine 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine 2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine 2-Methoxyethyl( a -methyl-3,4-methylenedioxyphenethyl)amine 2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine b -Methoxy-3,4-methylenedioxyphenethylamine 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine 2-( a -Methyl-3,4-methylenedioxyphenethylamino)ethanol a -Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine N -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine O -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine a -Methyl-4-(methylthio)phenethylamine b ,3,4,5-Tetramethoxyphenethylamine b ,2,5-Trimethoxy-4-methylphenethylamine; (c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N -alkylphenethylamine,a-methylphenethylamine, an N -alkyl-a-methylphenethylamine,a-ethylphenethylamine, or an N -alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents. (d) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say, (i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle; (ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups; (iii) by substitution in the piperidine ring with alkyl or alkenyl groups; (iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups; (v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group; (vi) by replacement of the N-propionyl group by another acyl group; (e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say, (i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted; (ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted; (iii) by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups; (iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group; (v) by formation of an N-oxide or of a quaternary base. (ea) any compound (not being a compound for the time being specified in sub-paragraph (a) above) with a maximum molecular mass of 500 atomic mass units and structurally derived from 2-(2-benzyl-benzimidazol-1-yl)ethanamine by modification in any of the following ways, that is to say— (i) by substitution at the nitrogen of the ethanamine to any extent by alkyl substituents containing up to three carbon atoms or alkenyl substituents containing up to three carbon atoms or by inclusion of the nitrogen atom (and no other atoms of the side chain) in a cyclic structure; (ii) by substitution in the phenyl ring of the benzyl system to any extent by alkyl or haloalkyl containing up to six carbon atoms, alkoxy or haloalkoxy containing up to five carbon atoms, acetyloxy, hydroxy, cyano, halogen, thioalkyl containing up to five carbon atoms or alkylsulphonyl containing up to five carbon atoms; (iii) by substitution at the 5- or 6- positions of the benzimidazole system by nitro, acetyl, cyano, methoxy, trifluoromethyl, trifluoromethoxy or halogen substituents; (iv) by substitution at the benzylic carbon by a methyl group; (v) by replacement of the benzylic carbon by a nitrogen, oxygen or sulphur atom; (vi) by substitution in the phenyl ring of the benzyl system by an ethoxy group linked back to the phenyl ring to form a dihydrobenzofuran structure; (vii) by replacement of the phenyl ring of the benzyl system by methylenedioxyphenyl. (f) any compound (not being benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from mescaline, 4-bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-dimethoxy-α,4-dimethylphenethylamine, N -hydroxytenamphetamine, or a compound specified in sub-paragraph (ba) or (c) above, by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.